Product image of Hepa Lichtenstein (Heparin Sodium) supplied by GNH India

Hepa Lichtenstein

Active Ingredient:
Heparin Sodium
Origin:
EU

Hepa Lichtenstein (Heparin Sodium)

Hepa Lichtenstein is a cutaneous product that contains heparin sodium as its active ingredient. It is marketed in the European Union and is classified as an anticoagulant and antithrombotic agent. The preparation is intended for topical application to support the body’s natural anticoagulant pathways. Heparin sodium works by enhancing antithrombin III activity, which reduces clot formation. The product is supplied without a listed strength and is intended for use under professional guidance.

Manufacturer / TM Owner

Winthrop Arzneimittel Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Hepa Lichtenstein is used as a topical anticoagulant to help prevent the formation of blood clots in specific clinical situations.

  • Prophylaxis of superficial thrombophlebitis after minor surgical procedures.
  • Adjunctive therapy for patients at risk of venous thromboembolism who require localized anticoagulation.
  • Support in the management of catheter‑related thrombosis when systemic anticoagulation is not indicated.
  • Prevention of clot formation in skin grafts or flap procedures.

Side Effects

Topical application of heparin sodium may be associated with local and systemic effects.

Common

  • Mild skin irritation at the application site.
  • Redness or erythema.
  • Minor bruising.
  • Localized itching.
  • Small amount of bleeding from the site.

Serious

  • Severe skin necrosis.
  • Allergic reactions such as urticaria or angioedema.
  • Uncontrolled bleeding or hematoma formation.
  • Heparin‑induced thrombocytopenia (HIT) in susceptible individuals.

Precautions & Warnings

When using Hepa Lichtenstein, several precautionary measures should be considered to minimize risk.

  • Assess the patient’s bleeding risk before initiating therapy.
  • Avoid use on open wounds or infected skin.
  • Do not apply excessive amounts; follow healthcare professional guidance.
  • Monitor for signs of skin necrosis or allergic reaction.
  • Use with caution in patients with known heparin sensitivity.
  • Consider renal or hepatic impairment may affect metabolism.

Avoid Interactions

Heparin sodium can interact with other agents that affect coagulation or platelet function.

Avoid

  • Concurrent use of other anticoagulants (e.g., warfarin, direct oral anticoagulants).
  • Systemic thrombolytic agents (e.g., alteplase).
  • High‑dose aspirin or non‑steroidal anti‑inflammatory drugs (NSAIDs).
  • Intravenous or subcutaneous heparin therapy.

Use with caution

  • Antiplatelet drugs such as clopidogrel.
  • Herbal supplements that may increase bleeding risk (e.g., ginkgo, garlic).
  • Vitamin K antagonists, requiring close monitoring of coagulation parameters.
  • Patients undergoing invasive procedures.

Frequently Asked Questions

The active ingredient in Hepa Lichtenstein is heparin sodium.

Hepa Lichtenstein is applied cutaneously (topically) to the skin according to the instructions of a healthcare professional.

It may be used for prophylaxis of superficial thrombophlebitis, as adjunctive therapy in patients at risk of venous thromboembolism, and to prevent clot formation in skin grafts, flap procedures, or catheter sites.

No, the product should not be applied to open or infected wounds.

Common side effects include mild skin irritation, redness, itching, minor bruising, and small amounts of bleeding at the application site.

Serious reactions such as severe skin necrosis, allergic responses (e.g., urticaria, angioedema), uncontrolled bleeding, hematoma, or heparin‑induced thrombocytopenia should be reported to a healthcare provider immediately.

Concurrent use with other systemic anticoagulants, thrombolytics, or high‑dose NSAIDs should be avoided unless specifically directed by a clinician.

The pregnancy safety category for Hepa Lichtenstein is not established; use only if clearly needed and after consulting a healthcare professional.

Patients should be monitored for signs of excessive bleeding, skin changes, and any allergic reactions. Laboratory monitoring may be required if systemic anticoagulation is also being used.

Herbal products that increase bleeding risk, such as ginkgo, garlic, or high‑dose vitamin E, should be used with caution and discussed with a healthcare provider.

The regulatory status of Hepa Lichtenstein varies by region; its availability as prescription‑only or over‑the‑counter has not been definitively classified.

Seek immediate medical attention, discontinue the product, and inform your healthcare provider of the reaction.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Heparin Sodium

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT